Atossa Therapeutics
ATOS
#10745
Rank
HK$0.15 B
Marketcap
HK$15.77
Share price
2.55%
Change (1 day)
156.85%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2026 (TTM): -HK$32.01

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$32.09. In 2025 the company made an earnings per share (EPS) of -HK$31.70 a decrease over its 2024 EPS that were of -HK$23.85.

EPS history for Atossa Therapeutics from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$32.011%
2025-HK$31.7032.89%
2024-HK$23.85-15.56%
2023-HK$28.2414.29%
2022-HK$24.7116.67%
2021-HK$21.18-90.86%
2020-HK$231.84-2.96%
2019-HK$238.90-63.09%
2018-HK$647.28-49.63%
2017-HK$1,285-57.87%
2016-HK$3,050-74.01%
2015-HK$11,736-9.18%
2014-HK$12,922-12.86%
2013-HK$14,82970.73%
2012-HK$8,68534.07%
2011-HK$6,478263.41%
2010-HK$1,783

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.41-263.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
HK$79.87-348.90%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$96.27-400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-HK$1.96-93.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-HK$1.65-94.87%๐Ÿ‡บ๐Ÿ‡ธ USA